Location: Home
  • search
  • go
  • Relate News
  • 3/12/2020Clearside and Arctic Vision Enter License Deal for Edema Drug XIPERE i...
  • 3/12/2020Chinese Oncology Drug Market to Rise 8.7% CAGR Before 2026: New Report
  • 3/11/2020XtalPi Announces Strategic Collaboration with Porton for Drug Crystall...
  • 3/11/2020China-controlled Penicillin G API Sees over 50% Price Hike
  • 3/11/2020Pharma Faces Clinical Trial Disruptions by Coronavirus Outbreak in Chi...
  • 3/11/2020Correvio Partners with Teson Pharma for CVD Drug Aggrastat in China
  • 3/11/2020EMA to Consider Coronavirus' Impact on EU Medicines Supply
  • 3/11/2020WuXi Biologics Completes Biologics Manufacturing Facility in Ireland
  • 3/11/2020Global Companies Expand the Reach of Their Cancer Drugs in China
  • 3/11/2020Trump to Issue Executive Order Aimed At Ending Medical and API Relianc...
  • 3/11/2020The Coronavirus Long Battle: Trump Admin To Attack China’s Pharmaceut...
  • 3/11/2020AmCham China's Business Climate Survey 2020 - US companies in China Ar...
  • 3/11/2020Harbour BioMed Announces U.S. IND Approval for Its Anticancer HBM4003
  • 3/11/2020Chinese Consortium in Advanced Talks to Take China Biologic Private
  • 3/11/2020Genscript's Legend Biotech Plans IPO to Fund CAR-T Pipeline
  • 3/11/2020BrightGene Censured for False Claim on Gilead's Coronavirus Drug
  • 3/11/2020NMPA Issues Five Standards for Essential Tracing Data Sets for MAHs an...
  • 3/10/2020Harbour BioMed and Mount Sinai to Co-develop Covid-19 Therapies
  • 3/9/2020USTR's 2019 Report for China's WTO Compliance Highlight IP and Trade I...
  • 3/6/2020Recent Executive Moves
  • 3/6/2020AmCham China Releases Extended COVID-19 Flash Survey Report
  • 3/6/2020IQVIA Looks into The Epidemic Impact on China Healthcare Industry
  • 3/5/2020China Issues Major Policy for Deepening Medical Insurance System Refor...
  • 3/5/2020Biocartis Announces New I/O Project with Bristol-Myers Squibb in China
  • 3/4/2020Alopexx Enters Licensing Deal with BJ Shenogen for Novel Immunocytokin...
  • 3/4/2020Takeda Eyes Immune Globulin Approach to Treating Covid-19
  • 3/4/2020Sihuan Starts Clinical Trial of Ebola Drug Favipiravir for COVID-19
  • 3/4/2020NHSA and MOHRSS Makes Name Changes to Certain Drugs Listed in the 2019...
  • 3/4/2020Sirona and BJ Huaxi Pharma Sign LOI for Commercial Partnership in Chin...
  • 3/4/2020Cardinal Health Settles with SEC for China-linked FCPA Allegations
  • Page:245/774 Total number of articles:23207: [First][<<] [243] [244] [245] [246] [247] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group